Veeva Systems (NYSE:VEEV) Price Target Raised to $275.00 at Morgan Stanley

Veeva Systems (NYSE:VEEV) had its price objective upped by stock analysts at Morgan Stanley from $215.00 to $275.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an “equal weight” rating on the technology company’s stock. Morgan Stanley’s price target suggests a potential downside of 2.15% from the company’s current price.

Other analysts have also recently issued reports about the company. Zacks Research cut Veeva Systems from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 14th. Robert W. Baird increased their price target on shares of Veeva Systems from $250.00 to $260.00 and gave the company an “outperform” rating in a research note on Thursday, June 4th. TD Cowen reaffirmed a “buy” rating on shares of Veeva Systems in a report on Monday. Barclays boosted their target price on Veeva Systems from $235.00 to $275.00 and gave the company an “overweight” rating in a report on Tuesday, August 18th. Finally, Stifel Nicolaus upped their target price on Veeva Systems from $230.00 to $275.00 and gave the company a “buy” rating in a research report on Monday, August 17th. Nineteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Veeva Systems has a consensus rating of “Moderate Buy” and an average price target of $262.58.

Veeva Systems Trading Up 14.8%

NYSE:VEEV opened at $281.06 on Thursday. The company has a market capitalization of $45.65 billion, a P/E ratio of 49.92, a PEG ratio of 1.06 and a beta of 0.92. The firm has a fifty day simple moving average of $203.41 and a 200-day simple moving average of $183.04. Veeva Systems has a 12 month low of $148.05 and a 12 month high of $310.50.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.13. The company had revenue of $927.96 million during the quarter, compared to the consensus estimate of $905.38 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.Veeva Systems’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.99 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Equities analysts forecast that Veeva Systems will post 6.65 EPS for the current year.

Insiders Place Their Bets

In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of Veeva Systems stock in a transaction that occurred on Thursday, August 13th. The stock was sold at an average price of $250.23, for a total value of $9,008,280.00. Following the transaction, the insider directly owned 19,449 shares in the company, valued at approximately $4,866,723.27. This trade represents a 64.92% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company’s stock.

Hedge Funds Weigh In On Veeva Systems

A number of large investors have recently bought and sold shares of the company. SHP Wealth Management acquired a new stake in shares of Veeva Systems in the 4th quarter worth $26,000. Compass Financial Management LLC purchased a new stake in shares of Veeva Systems in the second quarter valued at about $27,000. Activest Wealth Management increased its stake in shares of Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock worth $29,000 after acquiring an additional 127 shares during the period. Arlington Trust Co LLC acquired a new position in shares of Veeva Systems during the second quarter worth about $29,000. Finally, Field & Main Bank purchased a new position in Veeva Systems during the second quarter worth about $29,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Key Headlines Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva reported fiscal Q2 revenue of $928.0 million, up 17.6% year over year, while EPS of $2.35 exceeded the $2.22 analyst consensus. Subscription revenue increased 16% to $766.8 million. Veeva Announces Fiscal 2027 Second Quarter Results
• Positive Sentiment: Management issued fiscal Q3 revenue guidance of approximately $932 million-$935 million and EPS guidance of $2.33-$2.34, both above Wall Street expectations. Full-year fiscal 2027 EPS guidance of $9.21 and revenue guidance of about $3.7 billion also exceeded consensus estimates. Veeva Q2 2027 Earnings Call Transcript
• Positive Sentiment: Executives highlighted continued strength in Vault CRM, targeting more than 70% market share, and said the first Falcon customer deployments are expected this year. AI-related capabilities are also contributing to demand and revenue growth. Veeva CRM and Falcon Update
• Positive Sentiment: Needham reaffirmed its Buy rating, while Piper Sandler initiated coverage, adding favorable analyst attention following the earnings release. Needham Reaffirms Buy Rating
• Neutral Sentiment: Analyst commentary emphasized Veeva’s combination of recurring growth, strong margins and financial strength, but the stock’s elevated valuation—around 44 times earnings—leaves less room for execution or guidance disappointments.
• Negative Sentiment: The modest decline in the shares despite the earnings and guidance beats suggests investors may be taking profits or were already pricing in strong results. Near-term sentiment could remain sensitive to valuation and the pace of new product adoption.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.